| Breast Neoplasm studied in …STUDIED_INderived200 of 13,867show all (up to 200) |
|---|
| → studied in | NCT01113970Phase 1/Phase 2 · completed Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01758445Phase 2 · active not recruiting Proton Radiation for Stage II/III Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01766297Phase 2 · recruiting Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883062Phase 2 · active not recruiting Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer · condition mapped PROBABILISTIC · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598257Phase 2 · active not recruiting Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04072952Phase 1/Phase 2 · completed A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Participants With ER+/HER2- Locally Advanced or Metastatic Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04720209NA · active not recruiting Taking AIM at Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906395Phase 3 · active not recruiting Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038735Phase 3 · active not recruiting Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor. · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05132582Phase 3 · active not recruiting A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05296798Phase 3 · active not recruiting A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05856773Phase 3 · recruiting Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05877599Phase 1 · recruiting A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05891171Phase 1 · active not recruiting Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06058377Phase 3 · recruiting Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06505018NA · terminated Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06627712Phase 3 · recruiting SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06637150Phase 3 · recruiting Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06799065Phase 1/Phase 2 · recruiting First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328516enrolling by invitation Natural History Study of Early Life Exposures in Agriculture (ELEA) · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07396766NA · completed Dissemination of BREASTChoice AIM1-B · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07427394Phase 2 · recruiting Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07531836NA · recruiting Multicomponent Prehabilitation in Older Adults With Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578571Phase 1 · recruiting A Phase 1 Study of IM-1617 in Participants With Advanced Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619534recruiting Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07671092early Phase 1 · recruiting Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07706179Phase 2 · not yet recruiting Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer · condition mapped PROBABILISTIC · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07725172recruiting Radiation Therapy and Thymus Function in Young Women With Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823907NA · not yet recruiting Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma: Safety and Cosmetic Outcomes · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Fibroadenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847398NA · not yet recruiting Emergence of Predictive Metabolomic Biomarkers of Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer. · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07848061not yet recruiting A Master Regulator of Lipid-Associated Macrophage Function in Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07848243Phase 2 · recruiting Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006421completed Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00034216recruiting Collection of Blood From Patients With Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00043472completed Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068003enrolling by invitation Harvesting Cells for Experimental Cancer Treatments · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00475761completed Breast Mammogram and Tissue Study · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441089recruiting Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595957recruiting Genomic Services Research Program · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02791581NA · active not recruiting Understanding and Predicting Breast Cancer Events After Treatment · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412877Phase 2 · recruiting Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03451383recruiting Older Breast Cancer Patients: Risk for Cognitive Decline · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03734029Phase 3 · completed Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03762733enrolling by invitation Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03865992NA · active not recruiting Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04573231Phase 2 · completed Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer · condition mapped PROBABILISTIC · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05196087recruiting Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!) · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05440929recruiting Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05646862Phase 3 · recruiting A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05872295Phase 1 · recruiting IKS014 in Advanced Solid Tumors That Express HER2 · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05880160NA · completed Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06110793Phase 1/Phase 2 · active not recruiting A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06120283Phase 1 · recruiting BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06148038Phase 1 · recruiting CBD for Breast Cancer Primary Tumors · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787339Phase 2 · recruiting Capecitabine in Low Risk Triple Negative Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07039474recruiting The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07060807Phase 3 · recruiting A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07152782Phase 2 · recruiting T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222267Phase 1 · recruiting An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07297927recruiting ICG Lymphography Changes Before and After Radiotherapy in Breast Cancer Patients · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07372079Phase 2 · recruiting Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07380646Phase 2 · recruiting the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07391774Phase 3 · recruiting Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Estrogen Receptor-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432178Phase 3 · recruiting CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon） · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07553234NA · recruiting Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07698106Phase 1/Phase 2 · not yet recruiting Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07698366NA · recruiting Breast Ultrasound Screening in Elderly Women: A Multicenter Cluster Randomized Trial · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704476NA · recruiting EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844018Phase 2 · not yet recruiting ADC Based Therapy Accroding to HER2 Heterogeneous · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844291NA · not yet recruiting A Prospective, Open-label, Randomized Trial Comparing Switch to A1811 Versus Continued THP Neoadjuvant Therapy After THP Induction in HER2-Positive Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844473NA · recruiting Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844759NA · not yet recruiting SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844941NA · recruiting Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01723774Phase 2 · active not recruiting PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02188745Phase 2 · completed ER Reactivation Therapy for Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02945579NA · recruiting Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568656Phase 1/Phase 2 · completed Study to Evaluate CCS1477 in Advanced Tumours · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03697577completed CDK and Body Composition Study · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03702309recruiting Liquid Biopsy Evaluation and Repository Development at Princess Margaret · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874038Phase 3 · active not recruiting Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN) · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327543NA · recruiting Effects of Online Yoga on the Quality of Life of Breast Cancer Patients · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05498155Phase 2 · completed Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05528133Phase 2 · recruiting Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607849NA · completed Breast Cancer Screening Uptake: a Randomized Controlled Trial Assessing the Effect of a Decisional Aid · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05766891Phase 2/Phase 3 · recruiting Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05913713NA · completed HIIT Following Breast Cancer Chemotherapy · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06103864Phase 3 · recruiting A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05) · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06294574NA · recruiting Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06312176Phase 3 · recruiting A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377852Phase 3 · recruiting The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393374Phase 3 · recruiting Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06447623Phase 3 · active not recruiting Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06721065NA · recruiting A Study of Language Interpretation Solutions for People With Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06841354Phase 3 · recruiting A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855524Phase 2 · recruiting Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06966700Phase 3 · recruiting A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007559Phase 2 · recruiting ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07054190Phase 2 · recruiting A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07066189NA · recruiting Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179809NA · recruiting Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419880Phase 2 · not yet recruiting Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832279NA · recruiting 1-Week Versus 3-Week PBI · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840534NA · not yet recruiting Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU) · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840599NA · not yet recruiting Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841704NA · not yet recruiting NAUTILUS-04: No Axillary Surgical Treatment in Low-Risk Clinically Node-Negative Breast Cancer Without Whole-Breast Radiotherapy - A Prospective, Randomized, Phase III, Non-inferiority Clinical Trial · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842055completed AI-based Prognostic Factors Identification in Early-stage Invasive Lobular Breast Carcinoma · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Breast Lobular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842068completed Artificial Intelligence (AI) - Based Models for Biomarkers Prediction · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842614NA · completed Effect of a Brassicaceae-Enriched Diet on Menopausal Symptoms in Women With Breast Cancer Receiving Antiestrogen Therapy · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843121NA · completed Supervised Exercise in Women With Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843212NA · recruiting EFFECTS OF SPSIP BLOCK ON PERIOPERATİVE INFLAMMATION AND TLR4 IN BREAST CANCER SURGERY · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295893Phase 2 · active not recruiting Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02390427Phase 1 · completed Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02860000Phase 2 · completed Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220893NA · completed Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03573648Phase 2 · active not recruiting Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03716180Phase 1 · active not recruiting DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03927768active not recruiting Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP) · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04224272Phase 2 · completed Phase 2a Study of ZW25 in Combination With Palbociclib Plus Fulvestrant · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04570956Phase 2 · terminated Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Atypical Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04584255Phase 2 · active not recruiting Niraparib + Dostarlimab In BRCA Mutated Breast Cancer · condition mapped PROBABILISTIC · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384119Phase 1 · terminated Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05412225Phase 1 · recruiting A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05444998Phase 2 · completed Neoadjuvant Inetetamab and Pyrotinib and Nab-paclitaxel for HER2+Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05708235Phase 2 · active not recruiting A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05898789NA · recruiting Virtual Rehabilitation for Cancer Survivors · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05959291NA · active not recruiting Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer · condition mapped PROBABILISTIC · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06018337Phase 3 · active not recruiting A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06179303Phase 2 · recruiting Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06251544Phase 1 · recruiting TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06522568NA · recruiting Testing a Mammography Decision Intervention in a Rural Setting · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07407920Phase 2 · recruiting Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Early Stage HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07408856Phase 1 · recruiting CAN1012 in Pre-Malignant DCIS and LCIS · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Breast Lobular Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07595718recruiting AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07820228completed Survival Analysis of Early Triple Negative Breast Cancer (TNBC) Women Treated With Dose Dense Sequential Adjuvant Chemotherapy · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838649Phase 1 · not yet recruiting Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367676Phase 2 · terminated 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER) · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387553early Phase 1 · completed HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04040569Phase 1 · active not recruiting A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04144907NA · recruiting Protein Needs Study · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04222413Phase 1 · recruiting Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400695Phase 3 · recruiting A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2 · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04715958Phase 2/Phase 3 · active not recruiting SHAPE Neoadjuvant Chemotherapy Response · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04989504Phase 3 · active not recruiting Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253520Phase 1 · active not recruiting Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06534918NA · recruiting Precise Oncology Interventions in Nutrition and Training (OnPoint) · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618287Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06633276recruiting Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing) · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06999798Phase 1 · recruiting An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085767Phase 3 · recruiting Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer · condition mapped PROBABILISTIC · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07185568NA · not yet recruiting IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast-Conserving Surgery for Non-palpable Tumors · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214532NA · recruiting Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339176Phase 1/Phase 2 · recruiting Intratumoral N17350 in Advanced Solid Tumors · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07401381Phase 1 · recruiting A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07502352NA · recruiting Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM) · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07597993recruiting BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07711847NA · recruiting Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07804745active not recruiting Fertility Decision and Outcomes in Young Women With Breast Cancer · condition mapped PROBABILISTIC · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808086recruiting Role of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829848NA · recruiting Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic Therapy · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835698NA · not yet recruiting The Validation of ICBT Clinical Trial: Disease Stress Adjustment in Breast Cancer Patients · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836257Phase 2 · not yet recruiting A Phase II Study of Trastuzumab Deruxtecan (T-DXd) Plus Pyrotinib in HER2-Positive Advanced Breast Cancer After Progression on T-DXd · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174121Phase 2 · recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02484404Phase 1/Phase 2 · active not recruiting Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03766009NA · active not recruiting Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04994067recruiting Intra-Operative Radiation Registry · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05422794Phase 1 · recruiting Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06085833NA · recruiting ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06545045NA · recruiting Cognitive Rehabilitation Following Breast Cancer Treatment · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714617Phase 1 · terminated Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07114601Phase 1 · recruiting A Study of LY4257496 in Participants With Cancer (OMNIRAY) · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07174336Phase 3 · recruiting A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213791Phase 1 · recruiting A Study of LY4337713 in Participants With FAP-Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287098Phase 2 · recruiting A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07426913NA · recruiting Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab · condition mapped PROBABILISTIC · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07528768Phase 2 · not yet recruiting HEADWATERS: Gemcitabine vs Paclitaxel in Metastatic Triple-Negative Breast Cancer in Women of African Ancestry. · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07614620NA · recruiting Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619365Phase 2 · not yet recruiting Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07643831available Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07748377NA · not yet recruiting Increasing Breast and Colorectal Cancer Screening in the Community · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07770243NA · not yet recruiting AI-Based Symptom Management for Post-Treatment Breast Cancer Survivors · condition mapped PROBABILISTIC · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07801508Phase 1 · recruiting A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832396NA · enrolling by invitation Community Study to Increase Mammogram Screening Among Overdue Women · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833085NA · not yet recruiting CAIX-targeted PET/CT in Solid Tumors · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833566recruiting Biopsy-site-marker in Breast Cancer · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833891not yet recruiting Senocohort: Identification of Predictive Biomarkers in Breast Cancer Treatment · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835139NA · recruiting Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based Reconstruction · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02620852NA · recruiting Women Informed to Screen Depending on Measures of Risk (Wisdom Study) · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03357120NA · completed Circulating Tumor DNA After Neoadjuvant Chemotherapy · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03455270Phase 1 · completed G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer · condition mapped ONTOLOGY_EXACT · 13,867 trials mapped (3,690 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04084730Phase 2 · recruiting Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · condition mapped ALIAS · 13,867 trials mapped (3,690 active) | — | — | Invasive Breast Carcinoma of No Special Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644068Phase 1/Phase 2 · active not recruiting Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies · condition mapped CURATED_EXACT · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734262Phase 2 · active not recruiting A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) · condition mapped CURATED_BROADER · 13,867 trials mapped (3,690 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |